TY  - GEN
AU  - Davignon,J
TI  - Methods and endpoint issues in clinical development of lipid-acting agents with pleiotropic effects
SN  - 0002-9149
PY  - 1998///0618
KW  - Animals
KW  - Clofibrate
KW  - pharmacology
KW  - Drug Evaluation
KW  - methods
KW  - Drug Evaluation, Preclinical
KW  - Drugs, Investigational
KW  - Humans
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW  - Hyperlipidemias
KW  - drug therapy
KW  - Hypolipidemic Agents
KW  - Legislation, Drug
KW  - Probucol
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1016/s0002-9149(98)00253-7
ER  -